Arteriogenesis is the process of formation of new arterial blood vessels during development or in the adult circulation. In development it entails formation of new endothelial vascular structures with arterial identity as defined by expression of key markers such ephrin B2 and neuropilin 1 followed by acquisition of the media and adventitia. In the adult circulation new arteries arise either by expansion of the pre-existing arterial vascular structures or de novo. Deletion of VEGF, its receptor VEGFR2 or key intracellular signaling mediators results in failure of arterial vasculature development. Defective arteriogenesis is noted in other setting including deletion of eNOS or in disease states such as diabetes and hypercholesterolemia and this failure contributes greatly to morbidity u and mortality associated with these diseases. Nevertheless, the entire process is little understood and there are no currently successful approaches to deal with its defects in clinical settings. Understanding of molecular mechanism regulating arteriogenesis would be of great benefit to our understanding of pathobiology of major cardiovascular illnesses and to development of new therapeutic approaches to combat them. In this project we propose to focus on a newly discovered interaction between PI3K/Akt and ERK signaling pathways that appears to control arterial fate determination. Specifically we will 1) establish biological significance of Rafl SA-mediated decoupling of ERK and Akt signaling during development and in the normal vasculature;2) Determine biological significance of Rafl SA-mediated decoupling of ERK and Akt signaling in impaired arteriogenesis settings and 3) dissect how endothelial dysfunction alters VEGFR2 signaling in hypercholesterolemic conditions and study whether ERK activation mitigates this defect. Taken together, this set of experiments will provide a comprehensive look at this critical arterial fate-determining signaling cascade.

Public Health Relevance

The discovery of a signaling cascade controlling growth of new arteries will provide new insights and tools into developing new therapeutic strategies for treatment of atherosclerotic cardiovascular diseases including coronary, cerebral and peripheral vascular diseases.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Calabro, Nicole E; Kristofik, Nina J; Kyriakides, Themis R (2014) Thrombospondin-2 and extracellular matrix assembly. Biochim Biophys Acta 1840:2396-402
Ricard, Nicolas; Simons, Michael (2014) Fox(y) regulators of VEGF receptors. Circ Res 115:683-5
Faber, James E; Chilian, William M; Deindl, Elisabeth et al. (2014) A brief etymology of the collateral circulation. Arterioscler Thromb Vasc Biol 34:1854-9
Sundaram, Sumati; Echter, Andreana; Sivarapatna, Amogh et al. (2014) Small-diameter vascular graft engineered using human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A 20:740-50
Ju, Rong; Zhuang, Zhen W; Zhang, Jiasheng et al. (2014) Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways. J Biol Chem 289:510-9
Zhang, Xi; Simons, Michael (2014) Receptor tyrosine kinases endocytosis in endothelium: biology and signaling. Arterioscler Thromb Vasc Biol 34:1831-7
Huang, Angela H; Niklason, Laura E (2014) Engineering of arteries in vitro. Cell Mol Life Sci 71:2103-18
Goodwin, Julie E; Feng, Yan; Velazquez, Heino et al. (2014) Loss of the endothelial glucocorticoid receptor prevents the therapeutic protection afforded by dexamethasone after LPS. PLoS One 9:e108126
Morris, Aaron H; Kyriakides, Themis R (2014) Matricellular proteins and biomaterials. Matrix Biol 37:183-91
Gui, Liqiong; Boyle, Michael J; Kamin, Yishai M et al. (2014) Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 days. Tissue Eng Part A 20:1499-507

Showing the most recent 10 out of 16 publications